Salt hypertensive Dahl rats are characterized by sympathoexcitation and relative NO deficiency. We tested the hypothesis that the increased blood pressure (BP) response to fasudil in salt hypertensive Dahl rats is due to augmented calcium sensitization in the salt-sensitive strain and/or due to their decreased baroreflex efficiency. BP reduction after acute administration of nifedipine (an L-type voltage-dependent calcium channel blocker) or fasudil (a Rho kinase inhibitor) was studied in conscious intact rats and in rats subjected to acute NO synthase inhibition or combined blockade of the renin-angiotensin system (captopril), sympathetic nervous system (pentolinium), and NO synthase (L-NAME). Intact salt-sensitive (SS) Dahl rats fed a low-salt diet had greater BP responses to nifedipine (-31 ± 6 mmHg) or fasudil (-34 ± 7 mmHg) than salt-resistant (SR) Dahl rats (-16 ± 4 and -17 ± 2 mmHg, respectively), and a high-salt intake augmented the BP response only in SS rats. These BP responses were doubled after acute NO synthase inhibition, indicating that endogenous NO attenuates both calcium entry and calcium sensitization. Additional pentolinium administration, which minimized sympathetic compensation for the drug-induced BP reduction, magnified the BP responses to nifedipine or fasudil in all groups except for salt hypertensive SS rats due to their lower baroreflex efficiency. The BP response to the calcium channel blocker nifedipine can distinguish SS and SR rats even after calcium sensitization inhibition by fasudil, which was not seen when fasudil was administered to nifedipine-pretreated rats. Thus, enhanced calcium entry (potentiated by sympathoexcitation) in salt hypertensive Dahl rats is the abnormality that is essential for their BP increase, which was further augmented by increased calcium sensitization in salt-sensitive Dahl rats.

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177–85. PubMed DOI PMC

Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273:245–8. PubMed DOI

Loirand G. Rho kinases in health and disease: from basic science to translational research. Pharmacol Rev. 2015;67:1074–95. PubMed DOI

Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca PubMed DOI

Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension. 2002;39:438–42. PubMed DOI

Jin L, Ying Z, Hilgers RH, Yin J, Zhao X, Imig JD, et al. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats. J Pharmacol Exp Ther. 2006;318:288–95. PubMed DOI

Hilgers RH, Todd J Jr, Webb RC. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens. 2007;25:1687–97. PubMed DOI

Zicha J, Behuliak M, Pintérová M, Bencze M, Kuneš J, Vaněčková I. The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats. Physiol Res. 2014;63 Suppl 1:S19–27. PubMed DOI

Behuliak M, Pintérová M, Bencze M, Petrová M, Líšková S, Karen P, et al. Ca PubMed DOI

Behuliak M, Bencze M, Vaněčková I, Kuneš J, Zicha J. Basal and activated calcium sensitization mediated by Rhoa/Rho kinase pathway in rats with genetic and salt hypertension. Biomed Res Int. 2017;2017:8029728. PubMed DOI PMC

Vaněčková I, Behuliak M, Hojná S, Kopkan L, Kadlecová M, Zicha J. Exaggerated blood pressure response to fasudil or nifedipine in hypertensive Ren-2 transgenic rats: role of altered baroreflex. Hypertens Res. 2019;42:145–54. PubMed DOI

Löhn M, Steioff K, Bleich M, Busch AE, Ivashchenko Y. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation. Eur J Pharm. 2005;507:179–86. DOI

Dhaliwal JS, Casey DB, Greco AJ, Badejo AM Jr, Gallen TB, Murthy SN, et al. Rho kinase and Ca PubMed DOI

Brunová A, Bencze M, Behuliak M, Zicha J. Acute and chronic role of nitric oxide, renin-angiotensin system and sympathetic nervous system in the modulation of calcium sensitization in Wistar rats. Physiol Res. 2015;64:447–57. PubMed DOI

Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990–4. PubMed DOI

Zicha J, Dobešová Z, Vokurková M, Rauchová H, Hojná S, Kadlecová M, et al. Age-dependent salt hypertension in Dahl rats: fifty years of research. Physiol Res. 2012;61 Suppl 1:S35–87. PubMed DOI

Mark AL. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension. 1991;17 Suppl I:I86–90. PubMed

Huang BS, Leenen FH. Both brain angiotensin II and “ouabain” contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension. 1998;32:1028–33. PubMed DOI

Dobešová Z, Kuneš J, Zicha J. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies. J Hypertens. 2002;20:945–55. PubMed DOI

Gordon FJ, Matsuguchi H, Mark AL. Abnormal baroreflex control of heart rate in prehypertensive and hypertensive Dahl genetically salt-sensitive rats. Hypertension. 1981;3 Suppl I:I135–41. PubMed

Miyajima E, Buñag RD. Exacerbation of central baroreflex impairment in Dahl rats by high-salt diets. Am J Physiol. 1987;252:H402–9. PubMed

Garthoff B, Kazda S, Knorr A, Thomas G. Factors involved in the antihypertensive action of calcium antagonists. Hypertension. 1983;5:II34–8. PubMed DOI

Kazda S, Garthoff B, Luckhaus G. Calcium and malignant hypertension in animal experiment: effects of experimental manipulation of calcium influx. Am J Nephrol. 1986;6 Suppl 1:145–50. PubMed DOI

Boegehold MA. Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension. 1992;19:290–5. PubMed DOI

Rudd MA, Trolliet M, Hope S, Scribner AW, Daumerie G, Toolan G, et al. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition. Am J Physiol. 1999;277:H732–9. PubMed

Tan DY, Meng S, Manning RD Jr. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension. Hypertension. 1999;33:456–61. PubMed DOI

Sharma JN, Fernandez PG, Laher I, Triggle CR. Differential sensitivity of Dahl salt-sensitive and Dahl salt-resistant rats to the hypotensive action of acute nifedipine administration. Can J Physiol Pharmacol. 1984;62:241–3. PubMed DOI

Kuneš J, Hojná S, Kadlecová M, Dobešová Z, Rauchová H, Vokurková M, et al. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol Res. 2004;53 Suppl 1:S23–34. PubMed

Zicha J, Dobešová Z, Behuliak M, Kuneš J, Vaněčková I. Preventive dietary potassium supplementation in young salt-sensitive Dahl rats attenuates development of salt hypertension by decreasing sympathetic vasoconstriction. Acta Physiol. 2011;202:29–38. DOI

Zicha J, Dobešová Z, Kuneš J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens. 2001;19:247–54. PubMed DOI

Williams JM, Johnson AC, Stelloh C, Dreisbach AW, Franceschini N, Regner KR, et al. Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat. Hypertension. 2012;60:1157–68. PubMed DOI

Johnson AC, Wu W, Attipoe EM, Sasser JM, Taylor EB, Showmaker KC, et al. Loss of Arhgef11 in the Dahl salt-sensitive rat protects against hypertension-induced renal injury. Hypertension. 2020;75:1012–24. PubMed DOI

Nedvídek J, Zicha J. Baroreflex control of heart rate in young and adult salt hypertensive inbred Dahl rats. Physiol Res. 2000;49:323–30. PubMed

Ferrari AU, Mark AL. Sensitization of aortic baroreceptors by high salt diet in Dahl salt-resistant rats. Hypertension. 1987;10:55–60. PubMed DOI

Paulis L, Líšková S, Pintérová M, Dobešová Z, Kuneš J, Zicha J. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol. 2007;191:255–66. DOI

Pintérová M, Líšková S, Dobešová Z, Behuliak M, Kuneš J, Zicha J. Impaired control of L-type voltage-dependent calcium channels in experimental hypertension. Physiol Res. 2009;58 Suppl 2:S43–54. PubMed DOI

Zicha J, Dobešová Z, Behuliak M, Pintérová M, Kuneš J, Vaněčková I. Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system. Physiol Res. 2014;63:13–26. PubMed DOI

Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension. 2007;50:360–7. PubMed DOI

Morisawa N, Kitada K, Fujisawa Y, Nakano D, Yamazaki D, Kobuchi S, et al. Renal sympathetic nerve activity regulates cardiovascular energy expenditure in rats fed high salt. Hypertens Res. 2020;43:482–91. PubMed DOI

Van Meel JC, Timmermans PB, Van Zwieten PA. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses. Eur J Pharmacol. 1983;92:27–34. PubMed DOI

Nelson MT, Standen NB, Brayden JE, Worley JF. Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature. 1988;336:382–5. PubMed DOI

Lewis SJ, Bhopatkar MY, Walton TM, Bates JN. Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats. Eur J Pharmacol. 2005;528:144–9. PubMed DOI

Pintérová M, Karen P, Kuneš J, Zicha J. Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertusis toxin. J Hypertens. 2010;28:969–78. PubMed DOI

Manning RD Jr, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand. 2003;179:243–50. PubMed DOI

Vaněčková I, Vokurková M, Rauchová H, Dobešová Z, Pecháňová O, Kuneš J, et al. Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system. Acta Physiol. 2013;208:340–9. DOI

Zheng X, Chen M, Li X, Yang P, Zhao X, Ouyang Y, et al. Insufficient fumarase contributes to hypertension by an imbalance of redox metabolism in Dahl salt-sensitive rats. Hypertens Res. 2019;42:1672–82. PubMed DOI

Fleckenstein A, Frey M, Zorn J, Fleckenstein-Grün G. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile. Am J Cardiol. 1989;64:21I–34I. PubMed DOI

Nagasu H, Satoh M, Fujimoto S, Tomita N, Sasaki T, Kashihara N. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity. Hypertens Res. 2012;35:348–55. PubMed DOI

Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens. 2004;22:1787–96. PubMed DOI

Fukui S, Fukumoto Y, Suzuki J, Saji K, Nawata J, Tawara S, et al. Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats. J Cardiovasc Pharmacol. 2008;51:317–26. PubMed DOI

Behuliak M, Vavřínová A, Bencze M, Polgárová K, Ergang P, Kuneš J, et al. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2015;33:2443–54. PubMed DOI

Wirth A, Benyó Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med. 2008;14:64–8. PubMed DOI

Wiciński M, Szadujkis-Szadurska K, Węclewicz MM, Malinowski B, Matusiak G, Walczak M, et al. The role of Rho-kinase and calcium ions in constriction triggered by ET-1. Microvasc Res. 2018;119:84–90. PubMed DOI

Ferland DJ, Mullick AE, Watts SW. Chemerin as a driver of hypertension: a consideration. Am J Hypertens. 2020;33:975–86. PubMed DOI PMC

Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension